Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
10/21/1998 | EP0871654A1 Protegrins |
10/21/1998 | EP0871653A1 Novel amino acid derivatives, methods of producing them, and pharmaceutical compounds containing these compounds |
10/21/1998 | EP0871649A1 Conjugates of a polypeptide and a biocompatible polymer |
10/21/1998 | EP0871647A1 Oligomers which inhibit expression of collagen genes |
10/21/1998 | EP0871645A1 Modulators of the function of fas/apo1 receptors |
10/21/1998 | EP0871644A1 Platelet-endothelial cell adhesion molecule-1 compositions and methods |
10/21/1998 | EP0871643A1 Anti-viral guanosine-rich oligonucleotides |
10/21/1998 | EP0871628A1 Quinolizinone type compounds |
10/21/1998 | EP0871512A1 Localized intravascular delivery of growth factors for promotion of angiogenesis |
10/21/1998 | EP0871496A1 Arteriovenous and venous graft treatments: methods and compositions |
10/21/1998 | EP0871494A1 Compositions and methods for treating tumor cells |
10/21/1998 | EP0871487A1 Dendritic cell stimulatory factor |
10/21/1998 | EP0871486A1 Diphtheria toxin epitopes |
10/21/1998 | EP0871485A1 COMPOSITIONS AND METHODS FOR CATALYZING HYDROLYSIS OF HIV gp120 |
10/21/1998 | EP0871480A1 T cells mediating an immune response and methods of use |
10/21/1998 | EP0871478A1 Oral tolerance in skin diseases presenting with t-cell mediated inflammation |
10/21/1998 | EP0871477A1 Method for obtaining receptor agonist antibodies |
10/21/1998 | EP0871476A1 Dried blood factor composition comprising trehalose |
10/21/1998 | EP0871475A2 Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors |
10/21/1998 | EP0871474A1 Generation of human insulin |
10/21/1998 | EP0871473A1 Pharmaceutical composition containing il-10 |
10/21/1998 | EP0871472A1 Cytokines and their use in treatment and/or prophylaxis of breast cancer |
10/21/1998 | EP0871471A1 Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
10/21/1998 | EP0871470A1 Haemopoietic growth factor antagonists and uses therefor |
10/21/1998 | EP0871469A1 Nisin in combination with glycerol monolaurate active against helicobacter |
10/21/1998 | EP0871468A1 Methods for treating prostate cancer with lhrh antagonists |
10/21/1998 | EP0871467A1 Novel formulation for peptide release |
10/21/1998 | EP0871466A1 Method for the treatment or prevention of eczema/dermatitis |
10/21/1998 | EP0871465A1 Use of ritonavir (abt-538) for improving the pharmacokinetics of drugs metabolized by cytochrome p450 in a method of treating aids |
10/21/1998 | EP0871464A1 Bradykinin analogs as selective thrombin inhibitors |
10/21/1998 | EP0871463A1 Regulation of eating behavior |
10/21/1998 | EP0871462A1 Anti-obesity proteins |
10/21/1998 | EP0871461A1 Anti-obesity proteins |
10/21/1998 | EP0871458A1 Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment |
10/21/1998 | EP0871457A1 Isolated stromal cells and methods of using the same |
10/21/1998 | EP0871456A1 Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of gvhd |
10/21/1998 | EP0871455A1 In vitro growth of functional islets of langerhans and in vivo uses thereof |
10/21/1998 | EP0871454A1 Phosphorous-containing cysteine and serine protease inhibitors |
10/21/1998 | EP0871443A1 Advanced glycation end-product intermediaries and post-amadori inhibition |
10/21/1998 | EP0871433A2 Composition for sustained release of non-aggregated erythropoietin |
10/21/1998 | EP0871376A1 Enhancement of vascular function by modulation of endogenous nitric oxide production or activity |
10/21/1998 | EP0871363A1 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
10/21/1998 | EP0794824A4 Method and device for separating fibrin monomer from blood plasma |
10/21/1998 | EP0738327B1 Host-vector system for use in gene therapy |
10/21/1998 | EP0712307A4 Methods for b-cell population control |
10/21/1998 | EP0658199B1 Production of heterodimer pdgf-ab by means of a bicistronic vector system in mammalian cells |
10/21/1998 | EP0643719B1 Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor |
10/21/1998 | EP0529065B1 Receptor-based screening methods for amylin agonists and antagonists |
10/21/1998 | CN1196734A Anti-inflammatory agent |
10/21/1998 | CN1196733A AntiFas ligand antibodies and assay method by using same |
10/21/1998 | CN1196732A Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
10/21/1998 | CN1040330C Anti-bradykinin compound of N-terminal modification and preparation method and composition thereof |
10/20/1998 | US5824874 Antifungal polypeptide and process for its production |
10/20/1998 | US5824839 Delivery of gene products via mesangial cells |
10/20/1998 | US5824791 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease |
10/20/1998 | US5824789 Human growth factors, nucleotide sequence encoding growth factors, and method of use thereof |
10/20/1998 | US5824784 Genetic engineering with polypeptides and proteins |
10/20/1998 | US5824782 Immunoconjugates II |
10/20/1998 | US5824781 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
10/20/1998 | US5824780 Purified and isolated from human blood plasma or cell cultures and reacted with an activating agent |
10/20/1998 | US5824778 Chemically-modified G-CSF |
10/20/1998 | US5824776 Cell-targeted lytic pore-forming agents |
10/20/1998 | US5824775 Human netrin-1 |
10/20/1998 | US5824774 Chimeric isoprenoid synthases and uses thereof |
10/20/1998 | US5824771 Cyclic corticotropin-releasing factor peptides |
10/20/1998 | US5824770 Ikaros polypeptides |
10/20/1998 | US5824693 Method for treatment for pulmonary disease |
10/20/1998 | US5824681 Immunomodulating effect |
10/20/1998 | US5824662 Treatment of global and focal ischemia using naaladase inhibitors |
10/20/1998 | US5824660 Heparin/tissue factor pathway inhibitor for genetic engineering |
10/20/1998 | US5824655 Anti-transforming growth factor-β gene therapy |
10/20/1998 | US5824652 Heterocyclic acyldipeptides, processes for the preparation thereof and pharmaceutical compositions containing the same |
10/20/1998 | US5824650 Antiinflammatory agents for skin by applying topically substance p antagonist |
10/20/1998 | US5824649 Diagnosis, vaccines |
10/20/1998 | US5824648 Extraction of polysaccharide peptide with boiling water to form powder, centrifuging, filtration and purification with amino acid sequence |
10/20/1998 | US5824647 Chemotactic wound healing peptides |
10/20/1998 | US5824646 Administering calcitonin in combinatin with an adhesion promoter consisting of a nonionic surfactant and saturated aliphatic carboxylic acid |
10/20/1998 | US5824645 Method of treating inflammation |
10/20/1998 | US5824644 Method of attenuating arterial stenosis |
10/20/1998 | US5824643 Therapeutic uses of keratinocyte growth factor |
10/20/1998 | US5824642 Treatment of partial growth hormone insensitivity syndrome |
10/20/1998 | US5824641 Method of treating of preventing influenza |
10/20/1998 | US5824640 Substances of polypeptide nature useful in human therapy |
10/20/1998 | US5824639 Modified factor VII anticoagulant proteins |
10/20/1998 | US5824638 Oral insulin delivery |
10/20/1998 | US5824637 Inhibiting release of follicle stimulating hormone in a mammal, oligopeptides or polypeptides which complex with the activin receptor |
10/20/1998 | US5824636 Protein with amino acid sequence with antitumor effects |
10/20/1998 | US5824551 Method for modulating cell apoptosis |
10/20/1998 | US5824550 Voltage-gated calcium channel and antisense oligonucleotides thereto |
10/20/1998 | US5824549 Transformed human T cell |
10/20/1998 | US5824548 Method of increasing survival of cultured primate embryos in medium containing exogenous gonadotrophin releasor hormone |
10/20/1998 | US5824519 A dna sequence comprising a specific binding promoter encoding a ribozyme as antitumor agents, viricides, antiproliferative agents; drug delivery |
10/20/1998 | US5824510 Anticancer agents for gastrointestinal tracts and pancreatic ducts |
10/20/1998 | US5824509 Recombinant lymphotoxin cDNA and variants |
10/20/1998 | US5824508 Dna and amino acid sequences, vectors and host cells |
10/20/1998 | US5824507 Hepatitis G virus and molecular cloning thereof |
10/20/1998 | US5824505 Vectors, transformed cells and process for the preparation of hirudin |
10/20/1998 | US5824504 Polynucleotides |
10/20/1998 | US5824500 Nucleic acid encoding novel human KDEL receptor |
10/20/1998 | US5824492 Polypeptides having kinase activity, their preparation and use |